ZYBT Bathi sing dikarepake Jilin Zhengye Biotechnology

ZYBT (Jilin Zhengye Biotechnology) - tandha merek perusahaan

Zhengye Biotechnology (ZYBT) business is subject to the influence of agricultural cycles and R&D costs. The expected net profit metric visualizes the long-term trend, while the value of 0.00 captures this indicator. The company's revenues are based on the sale of veterinary vaccines. The strategic importance of its products for China's food sector and government support ensure steady growth for the biotechnology segment.

ZYBT - Bathi resik mangsa ngarep jlzybio.com ing rentang 08.01.2025 - 09.01.2025

Zhengye Bio - rincian analitis lan metrik utama (ZYBT)

Analisis dhasar perusahaan:ZYBT, Zhengye Biotechnology Co., Ltd.
Barang utama Jilin Zhengye Biotechnology

The expansion of Chinese pig farming and the implementation of new vaccines drive the operational efficiency of Zhengye Biotechnology (ZYBT). By analyzing the company's earnings forecast history, an investor assesses expected net income over decades, which allows for the identification of the asset's fundamental floor and the avoidance of value traps based on the consensus forecast of future business profitability.